z-logo
open-access-imgOpen Access
Cystic Fibrosis - Related Diabetes
Author(s) -
Marcin Makuch
Publication year - 2021
Publication title -
journal of education, health and sport
Language(s) - English
Resource type - Journals
ISSN - 2391-8306
DOI - 10.12775/jehs.2021.11.06.005
Subject(s) - cystic fibrosis related diabetes , cystic fibrosis , cystic fibrosis transmembrane conductance regulator , medicine , diabetes mellitus , pharmacotherapy , pathophysiology , disease , impaired glucose tolerance , gastroenterology , endocrinology , insulin resistance
Cystic fibrosis (CF) is life-shortening autosomal recessive disease, caused by mutations in the cystic fibrosis transmembrane conductance regulator protein. The most common of CF complications is cystic fibrosis-related diabetes (CFRD). The pathophysiology of CFRD is complex. The best test for screening and diagnosis of CFRD is the oral glucose tolerance test (OGTT). Insulin therapy is a treatment of choice in CFDR pharmacotherapy. An inseparable element of CFRD therapy is also physical activity and diet.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here